Literature DB >> 24682290

Trends with corticosteroid use in males with Duchenne muscular dystrophy born 1982-2001.

Deborah J Fox1, Anil Kumar2, Nancy A West3, A Gregory DiRienzo4, Katherine A James5, Joyce Oleszek6.   

Abstract

This study examines trends in corticosteroid use for males with Duchenne muscular dystrophy by birth year, race/ethnicity, and knowledge of Duchenne muscular dystrophy family history. Firstborn males (n = 521) selected from a population-based surveillance system of Duchenne muscular dystrophy were analyzed using Kaplan Meier and regression methods. Comparing males born 1982 to 1986 with males born 1997 to 2001, steroid use increased from 54% to 72% and mean age at steroid initiation decreased from 8.2 to 7.1 years. Hispanics and non-Hispanic Black males used steroids less frequently and delayed initiation compared to white males. Compared to males without a Duchenne muscular dystrophy family history, males with known family history were half as likely to use steroids. Duration of steroid use increased over time and age at initiation decreased. Racial/ethnic disparities exist for steroid use and should be addressed to improve outcome and quality of life for boys with Duchenne muscular dystrophy.
© The Author(s) 2014.

Entities:  

Keywords:  Duchenne muscular dystrophy; age of treatment initiation; health disparities; length of use; steroids

Mesh:

Substances:

Year:  2014        PMID: 24682290     DOI: 10.1177/0883073813517263

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  11 in total

1.  Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials.

Authors:  Jacob J Gissy; Teresa Johnson; Deborah J Fox; Anil Kumar; Emma Ciafaloni; Anthonie J van Essen; Holly L Peay; Ann Martin; Ann Lucas; Richard S Finkel
Journal:  Neuromuscul Disord       Date:  2017-07-21       Impact factor: 4.296

2.  Selected clinical and demographic factors and all-cause mortality among individuals with Duchenne muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research Network.

Authors:  Pangaja Paramsothy; Yinding Wang; Bo Cai; Kristin M Conway; Nicholas E Johnson; Shree Pandya; Emma Ciafaloni; Katherine D Mathews; Paul A Romitti; James F Howard; Catharine Riley
Journal:  Neuromuscul Disord       Date:  2022-04-30       Impact factor: 3.538

3.  Muscular Dystrophy Surveillance, Tracking, and Research Network pilot: Population-based surveillance of major muscular dystrophies at four U.S. sites, 2007-2011.

Authors:  ThuyQuynh N Do; Natalie Street; Jennifer Donnelly; Melissa M Adams; Christopher Cunniff; Deborah J Fox; Richard O Weinert; Joyce Oleszek; Paul A Romitti; Christina P Westfield; Julie Bolen
Journal:  Birth Defects Res       Date:  2018-08-02       Impact factor: 2.344

Review 4.  A Review of MD STAR net's Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017.

Authors:  Kashika M Sahay; Tiffany Smith; Kristin M Conway; Paul A Romitti; Molly M Lamb; Jennifer Andrews; Shree Pandya; Joyce Oleszek; Christopher Cunniff; Rodolfo Valdez
Journal:  J Child Neurol       Date:  2018-10-22       Impact factor: 1.987

5.  The effect of steroid treatment on weight in nonambulatory males with Duchenne muscular dystrophy.

Authors:  Molly M Lamb; Bo Cai; Julie Royer; Shree Pandya; Aida Soim; Rodolfo Valdez; Carolyn DiGuiseppi; Katherine James; Nedra Whitehead; Holly Peay; Swamy Y Venkatesh; Dennis Matthews
Journal:  Am J Med Genet A       Date:  2018-09-26       Impact factor: 2.802

6.  Characterizing Enrollment in Observational Studies of Duchenne Muscular Dystrophy by Race and Ethnicity.

Authors:  Alison M Barnard; Samuel L Riehl; Rebecca J Willcocks; Glenn A Walter; Amber M Angell; Krista Vandenborne
Journal:  J Neuromuscul Dis       Date:  2020

7.  Association of genetic mutations and loss of ambulation in childhood-onset dystrophinopathy.

Authors:  Gregory Haber; Kristin M Conway; Pangaja Paramsothy; Anindya Roy; Hobart Rogers; Xiang Ling; Nicholas Kozauer; Natalie Street; Paul A Romitti; Deborah J Fox; Han C Phan; Dennis Matthews; Emma Ciafaloni; Joyce Oleszek; Katherine A James; Maureen Galindo; Nedra Whitehead; Nicholas Johnson; Russell J Butterfield; Shree Pandya; Swamy Venkatesh; Venkatesh Atul Bhattaram
Journal:  Muscle Nerve       Date:  2020-11-17       Impact factor: 3.852

8.  Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne Natural History Study.

Authors:  Luca Bello; Akanchha Kesari; Heather Gordish-Dressman; Avital Cnaan; Lauren P Morgenroth; Jaya Punetha; Tina Duong; Erik K Henricson; Elena Pegoraro; Craig M McDonald; Eric P Hoffman
Journal:  Ann Neurol       Date:  2015-03-13       Impact factor: 10.422

9.  Trends in steroid therapy for Duchenne muscular dystrophy in Japan.

Authors:  Fumi Takeuchi; Hirofumi Komaki; Harumasa Nakamura; Naohiro Yonemoto; Kousuke Kashiwabara; En Kimura; Shin'ichi Takeda
Journal:  Muscle Nerve       Date:  2016-07-14       Impact factor: 3.217

Review 10.  The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review.

Authors:  S Ryder; R M Leadley; N Armstrong; M Westwood; S de Kock; T Butt; M Jain; J Kleijnen
Journal:  Orphanet J Rare Dis       Date:  2017-04-26       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.